Artelo Biosciences, Inc.
Artelo Biosciences, Inc. (ARTL) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
artl · stock forecast · 4 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $1.33
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.33 | ↑ 0.00% |
1-day model range: $1.28–$1.38. Peak: $1.38 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · ARTL · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-19 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2025-09-08 | D. Boral Capital | Downgrade ↓ | Buy→Hold |
| 2025-08-26 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-08-18 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-08-06 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-08-04 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-07-08 | D. Boral Capital | Upgrade ↑ | Hold→Buy |
| 2025-06-11 | D. Boral Capital | Downgrade ↓ | Buy→Hold |
| 2025-06-06 | D. Boral Capital | Maintains | Buy→Buy |
| 2025-04-28 | D. Boral Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Artelo Biosciences, Inc. (ARTL) stock. Of the recent 31 rating actions, 2 were upgrades and 5 were downgrades. 4 analysts currently cover ARTL.
Analyst Recommendation Trends
ARTL analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$49M
EPS This Year
$-9.84
EPS Next Year
$-5.28
↓ 46.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast ARTL EPS of $-9.84 for the current fiscal year, based on estimates from 1 analysts. The ARTL revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ARTL stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ARTL price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The ARTL short-term stock prediction for tomorrow is $1.33 (+0.00%).
Artelo Biosciences, Inc. trades on NASDAQ under the ticker ARTL. The ARTL stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
ARTL forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month ARTL price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $1.33.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.